Heterologous vaccine regimens against COVID-19

Talita Duarte-Salles, Daniel Prieto-Alhambra, D. (Dani) Prieto Alhambra

Research output: Contribution to journalComment/Letter to the editorPopular

30 Citations (Scopus)
Original languageEnglish
Pages (from-to)94-95
Number of pages2
JournalThe Lancet
Issue number10295
Publication statusPublished - 10 Jul 2021

Bibliographical note

Funding Information:
TD-S declares no competing interests. DP-A's research group has received research grants from the European Medicines Agency, the Innovative Medicines Initiative, Amgen, Chiesi, and UCB Biopharma; and consultancy or speaker fees from Astellas, Amgen, AstraZeneca, and UCB Biopharma, all outside of the area of work commented on here.

Cite this